NCT05194553View on ClinicalTrials.gov

Identification and Characterization of NAFLD in Turkey

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

June 15, 2023

Conditions
Non-Alcoholic Fatty Liver DiseaseLiver DiseasesFatty LiverMetabolic SyndromeOverweight and Obesity
Trial Locations (1)

Unknown

Pax Clinic, Istanbul

Sponsors

Collaborators (1)

Pax Clinic
All Listed Sponsors
collaborator

Pax Clinic

NETWORK

lead

Maastricht University

OTHER

NCT05194553 - Identification and Characterization of NAFLD in Turkey | Biotech Hunter | Biotech Hunter